Back to Search Start Over

Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment.

Authors :
Juul-Madsen K
Parbo P
Ismail R
Ovesen PL
Schmidt V
Madsen LS
Thyrsted J
Gierl S
Breum M
Larsen A
Andersen MN
Romero-Ramos M
Holm CK
Andersen GR
Zhao H
Schuck P
Nygaard JV
Sutherland DS
Eskildsen SF
Willnow TE
Brooks DJ
Vorup-Jensen T
Source :
Nature communications [Nat Commun] 2024 Feb 09; Vol. 15 (1), pp. 1224. Date of Electronic Publication: 2024 Feb 09.
Publication Year :
2024

Abstract

The peripheral immune system is important in neurodegenerative diseases, both in protecting and inflaming the brain, but the underlying mechanisms remain elusive. Alzheimer's Disease is commonly preceded by a prodromal period. Here, we report the presence of large Aβ aggregates in plasma from patients with mild cognitive impairment (n = 38). The aggregates are associated with low level Alzheimer's Disease-like brain pathology as observed by <superscript>11</superscript> C-PiB PET and <superscript>18</superscript> F-FTP PET and lowered CD18-rich monocytes. We characterize complement receptor 4 as a strong binder of amyloids and show Aβ aggregates are preferentially phagocytosed and stimulate lysosomal activity through this receptor in stem cell-derived microglia. KIM127 integrin activation in monocytes promotes size selective phagocytosis of Aβ. Hydrodynamic calculations suggest Aβ aggregates associate with vessel walls of the cortical capillaries. In turn, we hypothesize aggregates may provide an adhesion substrate for recruiting CD18-rich monocytes into the cortex. Our results support a role for complement receptor 4 in regulating amyloid homeostasis.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
2041-1723
Volume :
15
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
38336934
Full Text :
https://doi.org/10.1038/s41467-024-45627-y